Cardio3 BioSciences | Regenerative medecine for cardiac diseases

Our mission is to treat cardiac diseases,
one of the world's largest unmet medical needs.
Learn more about us
Our mission is to treat cardiac diseases,
one of the world's largest unmet medical needs.
Learn more about us
Our mission is to treat cardiac diseases,
one of the world's largest unmet medical needs.
Learn more about us

About us

Cardio3 BioSciences is a Belgian biotechnology company focused on the discovery, development and commercialisation of regenerative and protective therapies for the treatment of cardiac diseases

Cardio3 BioSciences pipeline includes research programmes and product candidates seeking to address the high unmet medical needs in HF and AMI

Cardio3 BioSciences Treats First Patients in World’s First Phase III Clinical Trial Using Pre-Programmed Cells for the Treatment of Heart Failure (En - Fr - Nl)
Cardio3 BioSciences raises €19 million through a Private Placement (En - Fr - Nl)

Next event

Tuesday, 4 June, 2013 IchemE meeting, Chemistry Centre, Burlington House, London, UK

More information

About us

Products

News

Next event